Polydex Pharmaceuticals Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Polydex Pharmaceuticals Limited with three other
pharmaceutical manufacturers in North America:
Canada House Cannabis Group Inc
sales of 10.56 million Canadian Dollars [US$8.32 million]
INDVR Brands Inc.
(1.21 million Canadian Dollars [US$951,058.35 ]
Vitality Products Inc
(802,775.00 Canadian Dollars [US$632,602.76 ]
During the second
quarter of 2022, sales at Polydex Pharmaceuticals Limited totalled
This is a drop of 10.3%
from the C$1.84 million in sales at the company during the second quarter in 2021.
During the first two
quarters of 2022, sales totalled C$2.71 million, which is
than through the first two quarters of 2021.
During the year ended January of 2021, sales at
Polydex Pharmaceuticals Limited were C$6.48 million (US$5.11 million).
decrease of 4.8%
versus 2020, when the company's sales were C$6.81 million.